Stonehage Fleming Financial Services Holdings Ltd Acquires Shares of 3,997 Cigna Group $CI

Stonehage Fleming Financial Services Holdings Ltd bought a new position in Cigna Group (NYSE:CI) in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 3,997 shares of the health services provider’s stock, valued at approximately $1,102,000.

Other hedge funds and other institutional investors have also modified their holdings of the company. GQG Partners LLC acquired a new stake in Cigna Group in the 2nd quarter valued at $1,628,918,000. Norges Bank acquired a new position in Cigna Group during the fourth quarter worth $1,019,790,000. Northwestern Mutual Wealth Management Co. raised its stake in Cigna Group by 13,333.2% during the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 3,165,408 shares of the health services provider’s stock worth $900,912,000 after acquiring an additional 3,141,844 shares in the last quarter. Bank of America Corp DE bought a new position in shares of Cigna Group during the second quarter valued at $827,692,000. Finally, Legal & General Group Plc bought a new position in shares of Cigna Group during the second quarter valued at $542,779,000. Institutional investors own 86.99% of the company’s stock.

Analyst Ratings Changes

Several equities research analysts have recently weighed in on CI shares. The Goldman Sachs Group upped their target price on shares of Cigna Group from $335.00 to $340.00 and gave the stock a “buy” rating in a report on Monday, May 4th. Piper Sandler cut their price target on shares of Cigna Group from $370.00 to $346.00 and set an “overweight” rating for the company in a report on Wednesday, June 3rd. Sanford C. Bernstein upped their price objective on shares of Cigna Group from $371.00 to $381.00 and gave the stock an “outperform” rating in a research note on Thursday, July 9th. Barclays raised their price objective on shares of Cigna Group from $304.00 to $310.00 and gave the stock an “equal weight” rating in a report on Friday, July 31st. Finally, Wells Fargo & Company lifted their target price on shares of Cigna Group from $305.00 to $307.00 and gave the company an “equal weight” rating in a research note on Friday, July 31st. Fifteen equities research analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $339.45.

Insider Buying and Selling

In other news, insider Nicole S. Jones sold 19,436 shares of the stock in a transaction that occurred on Tuesday, August 4th. The shares were sold at an average price of $276.27, for a total transaction of $5,369,583.72. Following the sale, the insider directly owned 27,256 shares of the company’s stock, valued at $7,530,015.12. This represents a 41.63% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CAO Jamie G. Kates sold 899 shares of the firm’s stock in a transaction that occurred on Friday, June 12th. The shares were sold at an average price of $298.61, for a total transaction of $268,450.39. Following the completion of the sale, the chief accounting officer directly owned 2,368 shares of the company’s stock, valued at approximately $707,108.48. This represents a 27.52% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 23,012 shares of company stock worth $6,386,550 over the last quarter. 0.60% of the stock is owned by company insiders.

Cigna Group Stock Performance

Shares of NYSE:CI opened at $277.21 on Friday. The business has a fifty day moving average of $283.53 and a 200-day moving average of $281.41. The company has a debt-to-equity ratio of 0.68, a quick ratio of 0.76 and a current ratio of 0.76. Cigna Group has a twelve month low of $239.51 and a twelve month high of $315.47. The firm has a market cap of $73.25 billion, a PE ratio of 11.47, a price-to-earnings-growth ratio of 0.97 and a beta of 0.29.

Cigna Group (NYSE:CI) last issued its quarterly earnings results on Thursday, July 30th. The health services provider reported $7.78 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.60 by $0.18. Cigna Group had a net margin of 2.27% and a return on equity of 19.75%. The business had revenue of $70.04 billion for the quarter, compared to the consensus estimate of $70.14 billion. During the same quarter in the prior year, the company earned $7.20 EPS. The firm’s quarterly revenue was up 6.7% on a year-over-year basis. Cigna Group has set its FY 2026 guidance at 30.450- EPS. On average, equities research analysts predict that Cigna Group will post 30.51 EPS for the current fiscal year.

Cigna Group Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, September 23rd. Shareholders of record on Tuesday, September 8th will be paid a $1.56 dividend. The ex-dividend date of this dividend is Tuesday, September 8th. This represents a $6.24 dividend on an annualized basis and a dividend yield of 2.3%. Cigna Group’s payout ratio is currently 25.82%.

About Cigna Group

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.